Conditional probability in autosomal recessive inheritance
Both parents are carriers of beta-thalassemia, meaning each has one normal beta-globin allele and one mutated allele. For any pregnancy, the possible combinations from two carrier parents follow a predictable pattern:
25% chance the child inherits two mutated alleles and has beta-thalassemia major,
50% chance the child inherits one mutated allele and is a carrier, and
25% chance the child inherits two normal alleles and is neither affected nor a carrier.
The key detail in this scenario is that the second child has already been shown
not to have the disease. This removes the
25% affected outcome from consideration. The remaining possibilities are the three unaffected genotypes: two of these are carriers, and one is a noncarrier.
Because the child is known to be unaffected, the probability of being a carrier is calculated only among the unaffected outcomes, giving 2 out of 3, or approximately 67%.
| Genotype | Alleles inherited | Clinical status | Included after knowing child is unaffected? |
|---|
| Homozygous normal | Normal + Normal | Unaffected, noncarrier | Yes (1 of 3 remaining) |
| Heterozygous carrier | Normal + Mutated | Unaffected, carrier | Yes (2 of 3 remaining) |
| Homozygous mutated | Mutated + Mutated | Beta-thalassemia major | No (excluded) |
Watch out! A common error is to answer
50% by recalling the general carrier probability for any pregnancy before knowing the child's phenotype. However, once the child is confirmed unaffected, the affected
25% is eliminated, and the denominator changes from 4 to 3.
The probability of being a carrier among unaffected children is 2/3, not 1/2.
This principle applies to any autosomal recessive condition when a child is known to be unaffected but carrier status is unknown. In thalassemia, carrier detection is clinically relevant because carriers may have mild microcytic anemia that can be mistaken for iron deficiency. According to the rapid evidence review, thalassemia should be suspected in patients with microcytic anemia and normal or elevated ferritin levels, which distinguishes it from iron deficiency anemia where ferritin is typically low
[1]. Carrier screening programs for thalassemia and other hemoglobinopathies are offered to people considering pregnancy or who are pregnant, allowing couples to understand reproductive risks before conception .
Key point! For autosomal recessive disorders, when a child is known to be unaffected, the carrier probability among unaffected siblings is always
2/3 (about
67%), regardless of which specific recessive condition is involved.
References (research sources)